NATURE IMMUNoLoGy | VOL 20 | JANUARY 2019 | 97-108 | www.nature.com/natureimmunology 97 Articles NaTuRe IMMuNoLogy the mediastinal lymph nodes (mLNs). In mice infected with PR8 for 15 days, we found that about 10% of the GC B cells bound the HA(PR8) tetramer and 40% bound the NP tetramer, but very few B cells bound the HA(X31) tetramer ( Fig. 1c ). Conversely, in mice infected with X31, about 4% of the GC B cells bound the HA(X31) tetramer and about 43% bound the NP tetramer, but very few bound the HA(PR8) tetramer (Fig. 1d ). We also observed both NP-specific and HA(PR8)-specific cells in the CD138 + plasmablast population and in the CD38 + IgD -PNAmemory B cell population in the mLNs of PR8-infected mice (Fig. 1e,f) .
D urable humoral immunity is maintained by long-lived, antibody-secreting plasma cells that home to the bone marrow 1,2 , as well as resting memory B cells that are poised to respond rapidly following a secondary encounter with antigen 3 . The generation of both cell types requires help from T cells, typically in the germinal center (GC), where B cells rapidly proliferate and are selected for high-affinity antigen receptors 4, 5 . As GC B cells differentiate into memory cells, they stop proliferating 6, 7 and, in some cases, home to mucosal surfaces 8, 9 . For example, pulmonary infection with influenza virus elicits memory B cells in the lung that express CXCR3 9 , whereas memory B cells responding to intestinal infection with rotavirus express mucosal homing receptors, such as α 4 β 7 integrin and CCR9 8 .
Early studies of memory B cells in the lung used limiting dilution and in vitro differentiation to indirectly enumerate memory B cells by enzyme-linked immunospot (ELISPOT 10 ) but did not directly characterize the memory B cells themselves. More recent studies use fluorescently labeled hemagglutinin (HA) to identify influenza-specific B cells in the lung and show that these cells have hallmarks of resident memory cells, such as the expression of CD69 9 . Importantly, following adoptive transfer, memory B cells from the lung respond more quickly to challenge infection than do those from lymphoid organs 9 , suggesting that memory B cells in different locations may be functionally distinct.
Although these studies imply that resident memory B (BRM) cells are generated following influenza infection, they do not test whether potential BRM cells in the lung recirculate or whether they alter the properties of a secondary B cell response following infection. In fact, it is not clear whether BRM cells in the lung would benefit pulmonary immunity. For example, lung-resident memory T (TRM) cells are a critical element of pulmonary immunity because they must physically contact MHC-expressing target cells in a secondary response in order to exert their effector functions 11 . In contrast, memory B cells either differentiate into antibodysecreting cells (ASCs) or re-enter the GC and undergo additional rounds of proliferation and selection 12, 13 . Both of these functions can be efficiently accomplished in draining lymph nodes. Given that antibodies generated in the lymph node circulate systemically and efficiently protect the lung 14 , it is not clear whether BRM cells might be useful or if they even exist at all.
Here we used parabiosis to definitively demonstrate the presence of BRM cells in the lung following influenza infection. We found that influenza-specific BRM cells, particularly IgM + BRM cells, were established early after influenza infection and were phenotypically distinct from their lymphoid counterparts. The formation of BRM cells that colonized the lung was dependent on early CD40dependent interactions with T cells in lymphoid organs. However, the placement of BRM cells in the lung also required encounter with antigen in the lung itself. Importantly, the presence of BRM cells in the lung led to a rapid secondary ASC response in the lung following a challenge infection. This rapid secondary response was maintained when mice were treated with the sphingosine-1-phosphate receptor 1 (S1P1R) agonist FTY-720 to prevent lymphocyte recirculation, suggesting that BRM cells differentiated in situ rather than in draining lymph nodes. Taken together, these data suggest that, along with resident memory T cells, BRM cells in the lung contribute to protection against secondary pulmonary infections.
Results
Identification of influenza-specific B cells. In order to identify influenza-specific B cells, we expressed recombinant nucleoprotein (NP) monomers with a biotinylation domain and a 6× his tag in Escherichia coli and expressed recombinant HA from the A/PR8/34 (PR8-H1N1) and A/X31 (X31-H3N2) viruses with a GNC4 trimerization domain and either a 6× his tag or a biotinylation (Avi) domain in 293 cells (Fig. 1a) . Following purification over a nickel column ( Fig. 1b) , we enzymatically biotinylated the purified recombinant HA protein, and 'tetramerized' the recombinant HA and NP proteins with fluorochrome-conjugated streptavidin to generate reagents that could be used in flow cytometry assays.
To determine whether our B cell tetramers could identify antigen-specific cells, we infected C57BL/6 mice with either PR8 or X31 and determined the frequency of tetramer-binding cells in the GC population (complete gating strategy in Supplementary Fig. 1 ) from B cells in PR8-infected mice (Fig. 1h ). Both IgM + memory B cells and isotype-switched memory B cells could be found in lungs, spleen and mLNs of PR8-infected mice, but not in those of naïve mice, on day 30 and day 70 after infection ( Supplementary  Fig. 2 ). These results demonstrate the specificity of the B cell tetramer reagents.
BRM cells in the lung and lymphoid tissues are distinct. To characterize non-circulating memory B cells in the mLNs, lung and spleen, we infected mice with PR8 and, 56 days later, infused them with fluorochrome-conjugated anti-B220 5 min prior to euthanasia. We subsequently gated on CD19 + B220 -(non-circulating) CD38 hi isotype-switched memory B cells and finally gated on NP-binding cells ( Fig. 2a-d ). We found that the majority of NP-specific isotype-switched memory B cells in the mLNs and spleen expressed CD73 ( Fig. 2e ), a marker noted in previous memory B cell studies 15 , whereas most isotype-switched memory B cells in the lung did not express CD73. NP-specific memory B cells in the lung also Fig. 1a ) and then on PNA + CD95 + GC B cells (c-d), or first gated on live, singlet lymphocytes ( Supplementary Fig. 1a ) and then on CD138 + plasmablasts (e), or first gated on live, singlet CD19 + IgDlymphocytes ( Supplementary Fig. 1b ) and then on PNA lo CD38 + memory B cells (f). Data are representative of four independent experiments with five mice. g-i, Cells from the mLNs of naïve mice (g), day 23 PR8-infected mice (h), and week 9 S. mansoni-infected mice (i) were gated on live, singlet CD19 + CD38 hi lymphocytes ( Supplementary Fig. 1c ) and analyzed for NP-specific and HA-specific isotype-switched (ISW) memory B cells. Data are representative of four experiments with five mice. eF450, eFluor 450; PE, phycoerythrin.
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NaTuRe IMMuNoLogy differed from those in the mLNs and spleen based on the expression of CD80 and PD-L2 ( Fig. 2f ). Resident memory T cells in the lung are often characterized using CD69 and CD103 11 . Although most NP-specific memory B cells in all three tissues expressed CD69, none of them expressed CD103 ( Fig. 2g ). Moreover, although approximately 12% of the BRM in mLNs and spleen expressed the LN homing receptor CD62L, almost none of the BRM cells in the lung expressed this marker ( Fig. 2h ). Finally, NP-specific memory B cells in the lung uniformly expressed high amounts of CXCR3, whereas those in the mLNs and spleen had a substantial population of CXCR3cells ( Fig. 2i ). These characteristics were generally shared by NP-specific isotype-switched memory B cells in the non-circulating (B220 -) and total (B220 +/-) populations ( Supplementary Fig. 3a-b ), although we should note that more than 95% of NP-specific isotype-switched memory B cells in the lung and mLNs are in the B220fraction. Despite the phenotypic differences between memory B cells in the lungs and lymphoid organs, the distribution of isotypes was remarkably similar, except for an increase in the frequency of IgM + BRM cells in the spleen ( Fig. 2j and Supplementary  Fig. 3c-e ). These results demonstrate that BRM cells in the lung are phenotypically different from their lymphoid counterparts.
BRM cells in the lung do not recirculate. To determine whether the non-circulating, influenza-specific memory B cells permanently resided in the lung, we infected C57BL/6 (CD45.2 + ) mice with influenza and, on day 44, surgically paired them with CD45.1 + partner mice for an additional 15 days to allow recirculating cells to equilibrate between the partners. To determine whether the pairs had reached equilibrium, we enumerated both donor (CD45.2 + ) and partner (CD45.2 -) naïve B cells in the mLNs and spleen. We found that naïve B cells had equilibrated between donor mice and partner mice in the mLNs and spleens of both mice in each pair ( Fig. 3a,b ).
We next gated on non-circulating IgM + or isotype-switched memory B cells in the lung and examined whether the NP-specific memory B cells had equilibrated ( Fig. 3c ). When PR8-memory mice were paired with naïve mice, NP-specific IgM + memory B cells as well as NP-specific isotype-switched memory B cells remained in the previously infected lung and did not migrate to the naïve lung ( Fig. 3d,e ). We also paired previously infected CD45.2 + mice with CD45.1 + mice that had previously received intranasal lipopolysaccharide (LPS) to promote pulmonary inflammation. Again, we found that NP-specific IgM + memory B cells as well as NP-specific, isotype-switched memory B cells remained in the previously infected lung and did not migrate to the LPS-treated lung ( Fig. 3f,g) . Finally, we paired previously infected CD45.2 + mice with previously infected CD45.1 + mice so that both lungs had been exposed to virus. Again, we found that NP-specific IgM + memory B cells as well as NP-specific, isotype-switched memory B cells remained in the lung of origin and did not migrate to the opposite lung ( Fig. 3h .0001 (f), ***P = 0.0002 and *P = 0.0105 (g), *P = 0.0471 and **P = 0.0042 (h), and *P = 0.0206 and ***P = 0.0008 (i). P < 0.05 is considered significant. j, Cells from the mLNs, lung and spleen of day 44 PR8-infected mice were gated on live, singlet lymphocytes ( Supplementary Fig. 1a ) and then gated on NP-specific CD19 + CD38 + IgDmemory B cells ( Supplementary Fig. 3c-e ), and the frequency of IgA-, IgG1-, IgG2b-, IgG2c-, IgG3-and IgM-expressing cells was determined. Data are representative of three independent experiments with five mice. AF647, Alexa Fluor 647; AF700, Alexa Fluor 700.
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suggest that antigen-specific memory cells in the lung are maintained as tissue resident cells (BRM cells) and do not migrate, even to previously infected lungs.
We also tested whether tissue residence was restricted to the lung or also occurred in the mLNs and spleen. Using PR8-infected CD45.1 + mice paired with PR8-infected CD45.2 + mice, we found that both HA-specific and NP-specific memory B cells in both the IgM + and isotype-switched fractions were strongly biased to remain in the lung of origin ( Supplementary Fig. 4a-d ). This bias was less pronounced in the mLNs and was only significant in the isotype-switched memory B cells ( Supplementary Fig. 4e -h). The bias was even less evident in the spleen but did achieve significance for NP-specific IgM + and isotype-switched memory B cells ( Supplementary Fig. 4i -l). IgD -eF450 1   45  54  52 47   250,000  200,000  150,000  100,000 50,000 0 10 3 10 1 10 2 10 3 10 4 10 4 10 5 0 SSC-A 250,000 200,000 150,000 100,000 50,000 0 10 3 10 4 10 5 0 Supplementary Fig. 1d ), and the frequency of CD45.2 + cells was determined in each partner. Data are combined from four independent experiments with three mice each. Graph shows individual points as well as mean ± s.d. c, Cells from the lung were gated on live, singlet lymphocytes ( Supplementary Fig. 1a ) and subsequently gated on CD19 + B220 -(non-circulating), 
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Memory B cells are established early after immunization 7 . To determine whether BRM cells in the lung are also established early after infection, we infected both CD45.1 + mice and CD45.2+ mice with PR8, surgically paired them 15 days later and evaluated the presence of BRM cells 15 days after joining. We found that naïve B cells in mLNs and spleen had equilibrated in the parabiotic pairs ( Fig. 4a,b ). However, after gating on non-circulating memory B cells ( Fig. 4c ), we found that NP-specific IgM + memory B cells as well as NP-specific isotype-switched memory B cells remained mainly in the partner of origin ( Fig. 4d,e ). HA-specific IgM + memory B cells as well as HA-specific, isotype-switched memory B cells also remained mainly in the partner of origin ( Fig. 4f,g) . Collectively, these findings demonstrate that many BRM cells in the lung are established very early after infection.
BRM cells are formed by early CD40-dependent mechanisms.
To establish the kinetics of GC formation relative to BRM cell generation, we enumerated antigen-specific GC B cells in the mLNs, as well as isotype-switched memory B cells in the blood and lung.
We found that GC B cells appeared in the mLNs as early as 7 days after infection, peaked around 15 days after infection and declined thereafter (Fig. 5a ). In contrast, memory B cells in both the blood ( Fig. 5b ) and lung ( Fig. 5c ) were barely detectable at day 7, but peaked at day 15 and declined thereafter.
To test whether the appearance of BRM cells in the lung was dependent on CD40 signalling, we infected mice with PR8 and treated them at various intervals with a blocking antibody to CD40L (MR1). We found that CD40L blockade for 2 weeks (regardless of when the treatment started) completely eliminated the GC B cell response in both the mLNs and the lung ( Fig. 5d -g). Early CD40L blockade prevented the placement of NP-specific IgM + and isotype-switched BRM cells in the lung (Fig. 5h ). Reductions in BRM cells were less pronounced when the blockade occurred between day 10 and day 20 ( Fig. 5i ) or between day 20 and day 30 ( Fig. 5j ). However, BRM cells in the lung were not reduced when CD40L was blocked between day 30 and day 40 ( Fig. 5k) , despite a complete loss of GC B cells in the mLNs and lung. We obtained a similar result when we examined HA-specific BRM cells ( Supplementary Fig. 5 ), Supplementary Fig. 1d ), and the frequency of CD45.2 + cells was determined in each partner. These data are combined from two independent experiments totalling eight pairs of mice. Graphs show individual data points as well as mean ± s.d. c, Cells from the lung were gated on live, singlet ( Supplementary Fig. 1a ) and subsequently gated on live, CD19 + B220 -(non-circulating), CD38 + IgD -IgM + (IgM) or CD38 + IgD -IgM -(ISW) memory B cells. d,e, The frequencies of NP-specific IgM + (d) and ISW (e) memory B cells from the lungs of host and partner mice. f,g, The frequencies of HA(PR8)-specific IgM + (f) and ISW (g) memory B cells from the lungs of host and partner mice. Data in c-g are representative of three independent experiments, each with four pairs of mice. Graphs show individual data as well as mean ± s.d. Significance was determined using one-way ANOVA (paired) followed by the Bonferroni-Sidak method for multiple comparison: *P = 0.0457 and ***P = 0.0002 (d), **P = 0.0047 and *P = 0.0213 (e), *P = 0.0285 and ***P = 0.0002 (f), and **P = 0.0060 and ## P = 0.0080 (g). P < 0.05 is considered significant. AF488, Alexa Fluor 488. Supplementary Fig. 1f ), and NP-specific as well as HA-specific cells were enumerated. b,c, Cells from the blood (b) and lungs (c) of PR8-infected mice were gated on live, singlet lymphocyte, CD19 + CD38 + IgM -IgD -ISW memory B cells ( Supplementary  Fig. 1c ), and the frequency (b) and number (c) of NP-specific as well as HA-specific cells were determined. Data are representative of three independent experiments with five mice at each time point. The data points represent mean ± s.d. d-k, Mice were infected with PR8 and administered anti-CD40L (MR1) or isotype-matched control antibody (CT) every other day for 10 days starting on day 5 (d, h), day 10 (e,i), day 20 (f,j) or day 30 (g,k) . Cells from the mLNs and lung were gated on live, singlet lymphocyte, CD19 + CD138 lo cells ( Supplementary Fig. 1g ) and subsequently gated on GL7 + CD38 lo GC B cells (d-g). Cells from the lung were gated on live, singlet lymphocyte, CD19 + CD138 lo CD38 + IgM + IgD -IgM BRM cells or CD19 + CD138 lo CD38 + IgM -IgD -ISW BRM cells (h-k) (gating in Supplementary Fig. 1g ). Data in d-k are representative of three independent experiments with five mice per group per timepoint. Graphs show mean ± s.d. as well as individual data points. Significance was determined using a Mann-Whitney U-test: **P = 0.0079 and ## P = 0.0014 (d), **P = 0.0079 and *P = 0.0462 (e), **P = 0.0079 and ## P = 0.0024 (f), *P = 0.0159 and # P= 0.0180 (g); or unpaired, two-tailed t-test: **P = 0.0018 and ***P = 0.0003 (h), and **P = 0.0011 (i). P < 0.05 is considered significant. PerCP, peridinin chlorophyll protein complex.
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although the IgM + BRM cells were placed in the lung as early as day 10, whereas the isotype-switched memory B cells required up to 30 days to fill the lung compartment. These data indicated that the seeding of influenza-specific BRM cells in the lung is dependent on early T cell interactions, possibly in the GC, and that IgM + BRM cells are seeded earlier than isotype-switched BRM cells.
BRM establishment in the lung is dependent on local antigen.
To test whether local antigen was needed for the placement of BRM cells in the lung, we surgically paired naïve mice, waited 15 days for them to attain equilibrium, infected one mouse with PR8 and the other with X31, and analyzed the influenza-specific BRM cells in the lungs 10 days later. After gating on non-circulating isotypeswitched memory B cells (Fig. 6a ), we found that PR8-infected partners had many more HA(PR8)-specific BRM cells than the X31-infected partners had (Fig. 6b ). Conversely, we found that the X31-infected partners had many more HA(X31)-specific BRM cells than the PR8-infected partners had (Fig. 6b ). Importantly, both partners had similar numbers of NP-specific BRM cells (Fig. 6b ). These data demonstrate that even in concurrently infected partner mice, BRM cells tend to stay in the lungs that express the antigen to which they respond.
We next tested whether antigen-non-specific pulmonary inflammation could recruit pre-existing systemic memory B cells to the lung. To do this, we infected mice with PR8 in the peritoneal cavity (or not), challenged them (or not) 30 days later with X31, and examined the placement of NP-specific, HA(X31)-specific and HA(PR8)specific memory B cells (Fig. 6c ). We found that peritoneal infection with PR8 did not elicit either NP-specific ( Fig. 6d) or HA(PR8)-specific ( Fig. 6e ) isotype-switched memory B cells in the lung. As expected, a pulmonary challenge with X31 elicited both NP-specific ( Fig. 6d ) and HA(X31)-specific ( Fig. 6f ) isotype-switched memory B cells in the lung. Importantly, pulmonary challenge with X31 also recruited HA(PR8)-specific isotype-switched memory B cells to the lung (Fig. 6e ). We observed similar results on day 10 ( Fig. 6d-f ) and day 45 ( Fig. 6g -i) after the challenge infection. We also examined IgM + memory B cells in the same experiment but found that so few HA(PR8)-specific IgM + memory B cells were recruited to the lungs that the result was not significant ( Supplementary Fig. 6c,f) . Taken together, these data indicate that BRM cells need to encounter antigen again for their placement in the lung.
BRM cells in the lung respond rapidly to infection.
To directly compare the ability of systemic or pulmonary infection to elicit BRM cells in the lung, we infected (or mock infected) mice in either the peritoneal cavity or the lung and, after 30 days, enumerated NP-specific B cells. As expected, naïve mice lacked NP-specific GC B cells ( Fig. 7a ) and isotype-switched memory B cells (Fig. 7b) , whereas the spleens of mice infected in the peritoneal cavity or the lung had numerous NP-specific GC and isotype-switched memory B cells. In contrast, only the lungs of mice intranasally infected with PR8 had NP-specific isotype-switched memory B cells (Fig. 7c) . To test the effect of lung BRM cells on the outcome of a challenge infection, we intraperitoneally, intranasally or mock infected mice with PR8, challenged all groups with X31 on day 30, measured weight loss over 2 weeks and assayed viral titers on day 35. We found that intranasally primed mice had the lowest drop in weight ( Fig. 7d ) and the lowest viral titers (Fig. 7e ). 
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Although intranasally infected mice have BRM cells, they also likely have resident memory T cells, which undoubtedly contribute to secondary immunity. To test whether BRM cells participate in pulmonary recall responses, we enumerated ASCs by ELISPOT in mice that were intraperitoneally, intranasally or mock infected for 30 days and subsequently challenged with X31 (or not) for 4 days. We found that naïve and peritoneally infected mice completely lacked NP-specific ASCs in their lungs before and after challenge, whereas intranasally infected mice had some NP-specific ASCs in the lung prior to challenge and had significantly more ASCs 4 days later (Fig. 8a) .
We performed a similar experiment in which BLIMP-1-yellow fluorescent protein (YFP) reporter mice were intraperitoneally, intranasally or mock infected for 30 days and subsequently challenged with X31 (or not) for 3 days. Given that ASCs strongly Supplementary Fig 1a) and subsequently gated on B220 -CD19 + CD38 hi IgM -IgD -ISW BRM cells (a). The frequency and number of HA(PR8)-specific (top row), HA(X31)-specific (middle row) and NP-specific (bottom row) BRM cells were determined in each partner (b). Data are representative of three independent experiments with five pairs of mice. Significance was determined using one-tailed, paired t-test: ****P = 0.0001 and *P = 0.0477. d-i, Mice were peritoneally infected with PR8 on day 0, intranasally challenged with X31 on day 30 and analyzed on day 40 (d-f) and day 75 (g-i). Cells from the lung were gated on live, singlet lymphocytes ( Supplementary Fig. 1a ) and subsequently gated on CD19 + B220 -CD38 + IgD -IgM -ISW memory B cells (c). NP-specific (d,g), HA(PR8)-specific (e,h) and HA(X31)-specific (f,i) ISW BRM cells were enumerated on day 40 (d-f) and day 75 (g-i). These data are representative of two independent experiments with five mice per timepoint. Data were analyzed with an unpaired t-test: ****P = 0.0001 (d), ***P = 0.0009 (e), **P = 0.0013 (f), **P = 0.0047 (g), **P = 0.0011 (h) and ***P = 0.0004 (i). P < 0.05 is considered significant. i.n., intranasal.
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NaTuRe IMMuNoLogy express BLIMP-1, we gated on the reporter, YFP, to enumerate ASCs in the lung. We found that naïve and peritoneally infected mice completely lacked NP-specific ASCs in their lungs before and after challenge, whereas intranasally infected mice had some NP-specific ASCs in the lung prior to challenge and had significantly more ASCs 3 days later (Fig. 8b) . To test whether the ASCs remaining in the lung following a primary infection declined over time, we performed the same experiment, but challenged the mice with X31 at day 60. We found a few remaining ASCs in the lungs of previously infected mice but a large increase in the pulmonary ASCs response in mice with lung BRM cells, but not in mice with systemic memory B cells (Fig. 8c ).
To ensure that the ASCs that we observed in the lungs of challenged mice were due to responding BRM cells and not recirculating memory B cells, we treated PR8 memory mice with fingolimod (FTY720) to block lymphocyte recirculation just before and after challenge with X31. We found that FTY720 did not reduce the NP-specific ASC response in the lung (Fig. 8d) , demonstrating that the observed spots were derived from BRM cells that differentiated in situ. We also examined the fate of the BRM cells that reacted with the challenge virus (NP specific) and the BRM cells that did not react with the challenge virus (HA(PR8) specific). We found that the NP-specific BRM cells declined after challenge (Fig. 8e ), whereas the HA(PR8)-specific BRM cells did not (Fig. 8f ). Collectively, these findings demonstrate that BRM cells in the lung are important for rapid secondary ASC responses and that inflammatory signals alone are insufficient to trigger the differentiation of BRM cells in the lung 16, 17 .
Discussion
Our data show that pulmonary infection with influenza virus elicits non-recirculating, lung-resident BRM cells. Unlike memory B cells in lymphoid organs, BRM cells in the lung uniformly express Supplementary Fig. 1h ), and NP-specific cells were enumerated in the spleen (a). Cells were gated on live, singlet lymphocyte CD19 + B220 -CD38 + IgD -IgMisotype-switched memory B cells ( Supplementary  Fig. 1e ), and NP-specific cells were enumerated in the spleen (b) and lung (c). Data are representative of three independent experiments with three mice in the naïve group, five mice in the intraperitoneally infected group and four mice in the intranasally infected group. Graphs show mean ± s.d. as well as individual data points. Significance was determined with a one-way ANOVA with Tukey's post-test for multiple comparisons: **P = 0.0038 (a), **P = 0.0021 (b), and ****P = 0.0001 (c). Articles NaTuRe IMMuNoLogy the chemokine receptor CXCR3 and completely lack the lymph node-homing receptor CD62L. Moreover, lung-resident BRM cells are evenly divided into CD73 + and CD73populations, whereas memory B cells in lymphoid organs are predominantly CD73 + . Influenza-specific BRM cells are recruited mainly to the lung in the first few weeks after infection, in part due to local antigen encounter. Finally, the presence of BRM cells in the lung leads to an accelerated ASC response in the lung following a challenge infection. These data demonstrate that like TRM cells, BRM cells are an instrumental component of pulmonary immunity to influenza. Supplementary Fig. 1a ) and subsequently gated on NP-specific YFP + cells. Data are representative of three independent experiments (b) or two experiments (c) with three to five mice per group. Graphs show individual data points as well as mean ± s.d. Data are analyzed by one-way ANOVA with Bonferroni-Sidak test for multiple comparisons: ***P = 0.0003, ****P = 0.0001, and ### P = 0.0001 (b); or Tukey's test for multiple comparisons: ****P = 0.0001, #### P = 0.0001 and P = 0.0001 (c). d, Mice were infected with PR8 on day 0, treated with FTY720 and challenged with X31 on day 30, and ELISPOTs in the lung were analyzed 4 days later. Data are representative of two independent experiments with six mice per group (control) or four mice per group (FTY720). Graph shows data points as well as mean ± s.d. Data were analyzed with a Mann-Whitney U-test. e,f, Mice were infected with PR8 on day 0, challenged with X31 on day 30 and analyzed on day 33. Cells from the lung were gated on live, singlet lymphocyte, CD19 + B220 -CD38 + IgD -IgM -ISW memory B cells ( Supplementary Fig. 1e ), and NP-specific (e) and HA(PR8)-specific (f) memory B cells were enumerated. Graphs show individual data points as well as mean ± s.d. Data are representative of three independent experiments with three mice per group. Data were analyzed with Student's t-test: *P = 0.0488. P < 0.05 is considered significant.
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The formation of BRM cells, like that of other memory B cells, is dependent on CD40 signaling, most likely in GCs. Interestingly, GCs are found in both the mLNs and the lungs of influenza-infected mice, and some studies suggest that GCs in the lung select mainly for influenza-specific memory B cells in the lung 18 . However, we find that the GC response in the mLNs develops very rapidly after infection, whereas the GC response in the lung develops more slowly, likely because it takes time to form inducible bronchus-associated lymphoid tissue (iBALT) 19, 20 . Given our observation that BRM cells in the lung are placed very early after infection and that CD40L blockade at late times has a minimal effect on lung-resident BRM cells, despite eliminating GCs in both the mLNs and the lung, it seems likely that most lung-resident BRM cells formed in response to a primary infection coming from GCs in the mLNs.
Interestingly, not all memory B cells transit through GCs, as mice lacking follicular helper T cells, and therefore GCs, still generate memory B cells 21 . Moreover, GC-independent memory B cells poorly express CD73 21 . Given our observation that more than half of the BRM cells in the lung lack CD73, it is possible that some of these cells were generated independently of the GC reaction either in the mLNs or in the lung. These data are also consistent with our observation that many BRM cells, particularly IgM + BRM cells, seed the lung very early after infection, and with previous studies showing that systemic memory B cells are also formed mainly early after immunization 7 .
Although memory B cells are generated mainly early after infection, we still observe them in the blood as late as 70 days after infection, suggesting that recirculating memory B cells could be recruited to the lungs for extended periods of time. In fact, we find that memory B cells established at systemic sites during a primary response can be 'called' into the lung by a subsequent inflammatory response in the lung, such as a non-specific infection. However, during a primary response, the placement of newly generated BRM precursors in the lung appears to be restricted to a limited time after infection. Moreover, as shown by our experiments with parabiotic mice concurrently infected with two different viruses, the ability to seed the lung is not dictated exclusively by inflammation, which is present in the lungs of both partners, but by the availability of local antigen, suggesting that BRM precursors need to contact antigen in the lung in order to stay (or survive) as lung-resident BRM cells. These data are similar to those showing that the placement of TRM cells in the skin and the lung requires contact with local antigen 22, 23 .
Where might this encounter with antigen occur? One possibility is that BRM precursors encounter antigen in iBALT 19, 20 . We know that iBALT is formed in the lungs of influenza-infected mice and that mice lacking conventional secondary lymphoid organs generate and maintain long-lived B cell responses 24 . Moreover, GC-like B cells are observed in the lungs of infected mice 19 , even though the existence of pulmonary follicular T cells remains controversial 25 , possibly due to the altered phenotype of helper T cells in peripheral non-lymphoid tissues 26 . Interestingly, GCs in the lung seem to preferentially select for broadly reactive memory B cells 18 , although it is unclear whether the broad reactivity of BRM cells is due to site-specific properties of the GC response or to the early placement of less stringently selected (and perhaps more broadly reactive) BRM cells. This latter idea is consistent with data showing that rapamycin treatment of influenza-infected mice leads to curtailed GC responses but a more broadly reactive repertoire of memory B cells 27 .
Our data highlight another qualitative difference between BRM cells in the lung and memory B cells in lymphoid organs: the rapidity of secondary responses. Mice with NP-specific BRM cells in the lung generate secondary ASC responses in the lungs more rapidly than do mice with memory B cells at systemic sites. Importantly, the accelerated secondary response in the lungs is maintained in the presence of FTY-720, a functional antagonist of the chemotactic molecule S1P1 28 , demonstrating that the response is generated in situ from precursors already in the lung. This change in secondary response time may be simply due to location, with BRM cells in the lung encountering antigen and inflammation earlier than their lymphoid counterparts and accelerating their response accordingly. Alternatively, BRM cells may be qualitatively different from those in lymphoid organs, as their phenotype suggests, and may be poised to rapidly differentiate into ASCs with minimal stimulation. Consistent with this idea, memory B cells from the lung (presumably BRM cells) adoptively transferred to recipient mice provide more efficient protection than that provided by memory B cells isolated from secondary lymphoid organs 9 .
In summary, our data demonstrate that influenza-specific BRM cells are formed in the lung following pulmonary influenza infection and that these cells are necessary for an accelerated ASC response following challenge infection. BRM cells are formed early after infection and seed the lung in a process that depends on local encounter with antigen. These data suggest that vaccines designed to elicit highly effective, long-lived protection against influenza virus infection will need to deliver antigens to the respiratory tract.
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